The Modern Diagnostic And Research Centre IPO GMP is ₹17. If this trend continues, the expected listing could be near ₹107.00 [18.89%]. Still, investors are advised to focus on the company’s fundamentals rather than relying solely on grey market movements.
Modern Diagnostic And Research Centre IPO of 40,99,200 equity shares of the face value of ₹10 aggregating up to ₹36.89 Crores. The IPO issue priced at ₹85 to ₹90 per share. The IPO will open on December 31, 2025 and will close on January 02, 2026.
Modern Diagnostic And Research Centre IPO GMP Trend [Day Wise]
The Modern Diagnostic And Research Centre IPO GMP prices shown here are only news related to the grey market. We do not trade/deal in the grey market or under the rates, and not do we recommend trading in the grey market.
Modern Diagnostic And Research Centre IPO Daily GMP Live Trends…
| Date | Price | GMP | SSR | ELP |
|---|---|---|---|---|
| 06/01/2026 | ₹90 | ₹17 | 20700 | ₹107.00 [18.89%] |
| 05/01/2026 | ₹90 | ₹17 | 20700 | ₹107.00 [18.89%] |
| 04/01/2026 | ₹90 | ₹17 | 20700 | ₹107.00 [18.89%] |
| 03/01/2026 | ₹90 | ₹17 | 20700 | ₹107.00 [18.89%] |
| 02/01/2026 | ₹90 | ₹17 | 20700 | ₹107.00 [18.89%] |
| 01/01/2026 | ₹90 | ₹12 | 14600 | ₹102.00 [13.33%] |
| 31/12/2025 | ₹90 | ₹13 | 15800 | ₹103.00 [14.44%] |
| 30/12/2025 | ₹90 | ₹10 | 12200 | ₹100.00 [11.11%] |
| 29/12/2025 | ₹90 | ₹0 | — | ₹90.00 [0.00%] |
| 28/12/2025 | ₹90 | ₹0 | — | ₹90.00 [0.00%] |
| 27/12/2025 | ₹90 | ₹0 | — | ₹90.00 [0.00%] |
| 26/12/2025 | ₹90 | ₹0 | — | ₹90.00 [0.00%] |
| 25/12/2025 | ₹90 | ₹0 | — | ₹90.00 [0.00%] |
| 24/12/2025 | ₹90 | ₹0 | — | ₹90.00 [0.00%] |
Read Also: Modern Diagnostic And Research Centre IPO Subscription Data
Key Factors Affecting GMP
- Company Performance and Fundamentals: The financial health of the company issuing the Modern Diagnostic And Research Centre IPO, its revenue growth, profitability, and market reputation directly affect its GMP. Companies with strong fundamentals typically attract higher premiums.
- Market Sentiment: Bullish market conditions tend to push GMP higher, as investors are optimistic about new listings. In contrast, during bearish conditions, GMP may turn negative, reflecting uncertainty.
- Demand-Supply Scenario: High demand for the Modern Diagnostic And Research Centre IPO usually leads to higher GMP, as investors are willing to pay a premium for early access to shares.
- Market Liquidity: In liquid markets, where trading volumes are high, the GMP tends to be more accurate as large volumes of shares are traded, offering a better gauge of investor sentiment.
Modern Diagnostic And Research Centre IPO GMP Facts
- GMPs are typically higher for the Modern Diagnostic And Research Centre IPO of well-known companies with strong fundamentals.
- GMPs are also likely to be higher for heavily subscribed the Modern Diagnostic And Research Centre IPO.
- Regardless of the GMP, it is important to do your own research before investing in the Modern Diagnostic And Research Centre IPO.
Modern Diagnostic And Research Centre IPO GMP Disclaimer
- GMP is not an indicator of the final listing price: GMP is only a reflection of the demand and supply of Modern Diagnostic And Research Centre IPO shares in the grey market. The final listing price will depend on a number of factors, including overall market sentiment and the company’s performance in the post-IPO period.
- GMP can be volatile: GMP can fluctuate significantly in the days leading up to the Modern Diagnostic And Research Centre IPO listing. This is due to uncertainty over the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the Modern Diagnostic And Research Centre IPO shares will list at a profit. The final listing price may be lower than the GMP, or the value of the shares may decline after listing.
- Investing in Modern Diagnostic And Research Centre IPOs is risky: IPO are considered to be high-risk investments. There is always a possibility that the company may fail, or the shares may underperform in the future.
Modern Diagnostic And Research Centre IPO GMP FAQs
What is the Grey Market Premium (GMP) of Modern Diagnostic And Research Centre IPO today?
The Grey Market Premium (GMP) of Modern Diagnostic And Research Centre IPO today is ₹17.
What is Modern Diagnostic And Research Centre IPO Expected Returns?
The Modern Diagnostic And Research Centre IPO Expected Returns is 18.89%.
When will the basis of allotment for the Modern Diagnostic And Research Centre IPO be finalized?
The Modern Diagnostic And Research Centre IPO allotment is expected to be finalized on January 05, 2026.
When will the shares of Modern Diagnostic And Research Centre IPO get listed?
The IPO shares are expected to be listed on the BSE and SME on January 07, 2026.
Disclaimer: Readers are strongly advised to seek guidance from a qualified financial advisor before making any investment decisions. Relying solely on the content presented here for financial choices is done entirely at the reader’s own risk.
| Thank You… |
|---|